No abstract available
Keywords:
anticoagulant; dabigatran; hemorrhage; idarucizumab.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antidotes / therapeutic use*
-
Antithrombins / adverse effects
-
Clinical Trials, Phase I as Topic
-
Dabigatran / adverse effects*
-
Hemorrhage / chemically induced*
-
Hemorrhage / drug therapy*
-
Humans
-
Protein Structure, Tertiary
Substances
-
Antibodies, Monoclonal, Humanized
-
Antidotes
-
Antithrombins
-
idarucizumab
-
Dabigatran